A detailed history of Archer Investment Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Archer Investment Corp holds 356 shares of UTHR stock, worth $166,038. This represents 0.03% of its overall portfolio holdings.

Number of Shares
356
Previous 325 9.54%
Holding current value
$166,038
Previous $93.4 Million 59.8%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$274.7 - $438.75 $8,515 - $13,601
31 Added 9.54%
356 $149 Million
Q2 2025

Aug 12, 2025

SELL
$276.47 - $328.4 $218,411 - $259,435
-790 Reduced 70.85%
325 $93.4 Million
Q1 2025

May 05, 2025

BUY
$304.42 - $380.78 $98,936 - $123,753
325 Added 41.14%
1,115 $344 Million
Q3 2024

Nov 06, 2024

BUY
$311.04 - $363.55 $245,721 - $287,204
790 New
790 $283 Million
Q1 2023

May 09, 2023

BUY
$212.99 - $276.17 $48,774 - $63,242
229 New
229 $51.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.